Use of Nivolumab Expanded to Sixth Cancer Type
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved expanding the use of the...
Tag: Nivolumab
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved expanding the use of the...
The FDA has approved nivolumab for treating patients with recurrent or metastatic squamous cell carcinoma of the head...
Late last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...
Earlier this week, new ground was broken in the field of cancer immunotherapy when the U.S. Food and Drug...
This year, at the AACR Annual Meeting held in Philadelphia April 18 to 22, an astounding 19,300 members of...
The field of cancer immunotherapy broke new ground last week when the U.S. Food and Drug Administration (FDA) announced...
Cancer immunotherapy, which entered 2014 with the accolade of Science magazine’s Breakthrough of the Year for 2013, ended the...
Lung cancer awareness month started hot on the heels of two exciting pieces of news that highlight the promise...